StratiCELL is increasing its panel of in vitro efficacy tests to study the cellular mechanisms leading to skin wound closure.
Topical treatments favouring the healing phases are required to avoid poor or impaired wound repair, in particular for chronic wounds.
StratiCELL offers multiple in vitro assays to demonstrate the ability of promoting molecules or dressings to influence the regeneration of the epidermis, the angiogenic process, and the effective remodelling of the dermal matrix.
Available assays are completely in line with a pre-clinical release of innovative skin care solutions to help repair damaged tissue.
